Literature DB >> 4577416

Interferon sensitivity of Venezuelan equine encephalomyelitis virus.

G W Jordan.   

Abstract

Two strains of Venezuelan equine encephalomyelitis virus, which differ in virulence for mice, have been studied for their production of and sensitivity to chick and mouse interferon. Little interferon was produced by chick cells in response to the virulent Trinidad strain or the attenuated TC-83 strain without either aging or priming the cultures. Consistent differences in the production of chick interferon were not found between the two strains. Plaque variants of the Trinidad strain produced higher titers of mouse interferon than the TC-83 strain in both primed and control L-cell cultures. The TC-83 strain was found to be more sensitive than the Trinidad strain to the inhibitory effects of interferon. The greater sensitivity of the TC-83 strain was observed at both high and low multiplicities and for both chick and mouse interferons. These results are consistent with the hypothesis that interferon sensitivity may have a role as a determinant of virulence in some virus-host systems.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4577416      PMCID: PMC422782          DOI: 10.1128/iai.7.6.911-917.1973

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  16 in total

1.  PRODUCTION OF INTERFERON BY NEWBORN AND ADULT MICE INFECTED WITH SINDBIS VIRUS.

Authors:  J VILCEK
Journal:  Virology       Date:  1964-04       Impact factor: 3.616

2.  VIRULENCE AND INTERFERON PRODUCTION OF STRAINS OF FOOT-AND MOUTH DISEASE VIRUS.

Authors:  R F SELLERS
Journal:  J Immunol       Date:  1964-07       Impact factor: 5.422

3.  INTERFERON PRODUCTION AND SENSITIVITY OF SEMLIKI FOREST VIRUS VARIANTS.

Authors:  N B FINTER
Journal:  J Hyg (Lond)       Date:  1964-09

4.  USE OF AN ATTENUATED STRAIN OF VENEZUELAN EQUINE ENCEPHALOMYELITIS VIRUS FOR IMMUNIZATION IN MAN.

Authors:  R W MCKINNEY; T O BERGE; W D SAWYER; W D TIGERTT; D CROZIER
Journal:  Am J Trop Med Hyg       Date:  1963-07       Impact factor: 2.345

5.  BIOLOGIC PROPERTIES OF TWO PLAQUE VARIANTS OF VESICULAR STOMATITIS VIRUS (INDIANA SEROTYPE).

Authors:  R R WAGNER; A H LEVEY; R M SNYDER; G A RATCLIFF; D F HYATT
Journal:  J Immunol       Date:  1963-07       Impact factor: 5.422

6.  RELATIONSHIP BETWEEN VIRUS MULTIPLICATION AND INTERFERON PRODUCTION IN MOUSE LUNGS AFTER INFECTION WITH ADAPTED AND UNADAPTED INFLUENZA VIRUSES.

Authors:  F LINK; D BLASKOVIC; J RAUS
Journal:  Acta Virol       Date:  1965-01       Impact factor: 1.162

7.  Studies on the virus of Venezuelan equine encephalomyelitis in Trinidad, W.I. I. The 1943-1944 epizootic.

Authors:  W D TIGERTT; W G DOWNS
Journal:  Am J Trop Med Hyg       Date:  1962-11       Impact factor: 2.345

8.  Quantitative aspects of interferon-induced plaque reduction: kinetics of interferon action.

Authors:  G W Jordan
Journal:  Virology       Date:  1972-05       Impact factor: 3.616

9.  Changes in the production of interferon in the process of adaptation of influenza type A2 virus to the mouse lung.

Authors:  A D Inglot; M Lobodzińska; I Biernacka; E Niedźwiedzka
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  1966       Impact factor: 4.291

10.  Persistent antigenic variation of influenza A viruses after incomplete neutralization in ovo with heterologous immune serum.

Authors:  I ARCHETTI; F L HORSFALL
Journal:  J Exp Med       Date:  1950-11-01       Impact factor: 14.307

View more
  11 in total

1.  Response of irradiated mice to live-virus (TC-83) immunization.

Authors:  R O Spertzel; D E Hilmas; J R Brown; D W Mason
Journal:  Infect Immun       Date:  1975-03       Impact factor: 3.441

2.  Biological characteristics of a stimulatory factor for viral replication detected in egg fluids.

Authors:  E Eylan; A Gazit
Journal:  Arch Virol       Date:  1978       Impact factor: 2.574

3.  Role of alpha/beta interferon in Venezuelan equine encephalitis virus pathogenesis: effect of an attenuating mutation in the 5' untranslated region.

Authors:  L J White; J G Wang; N L Davis; R E Johnston
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

4.  An attenuated variant of Eastern encephalitis virus: biological properties and protection induced in mice.

Authors:  A Brown; J E Officer
Journal:  Arch Virol       Date:  1975       Impact factor: 2.574

5.  Evaluation of various analogues of tilorone hydrochloride against Venezuelan equine encephalitis virus in mice.

Authors:  R W Kuehne; W L Pannier; E L Stephen
Journal:  Antimicrob Agents Chemother       Date:  1977-01       Impact factor: 5.191

6.  Replicon particles of Venezuelan equine encephalitis virus as a reductionist murine model for encephalitis.

Authors:  Alexandra Schäfer; Alan C Whitmore; Jennifer L Konopka; Robert E Johnston
Journal:  J Virol       Date:  2009-02-18       Impact factor: 5.103

7.  C3H/HeN mouse model for the evaluation of antiviral agents for the treatment of Venezuelan equine encephalitis virus infection.

Authors:  Justin G Julander; Ramona Skirpstunas; Venkatraman Siddharthan; Kristiina Shafer; Justin D Hoopes; Donald F Smee; John D Morrey
Journal:  Antiviral Res       Date:  2008-02-13       Impact factor: 5.970

8.  Acute infection with venezuelan equine encephalitis virus replicon particles catalyzes a systemic antiviral state and protects from lethal virus challenge.

Authors:  Jennifer L Konopka; Joseph M Thompson; Alan C Whitmore; Drue L Webb; Robert E Johnston
Journal:  J Virol       Date:  2009-09-30       Impact factor: 5.103

9.  Resistance to alpha/beta interferons correlates with the epizootic and virulence potential of Venezuelan equine encephalitis viruses and is determined by the 5' noncoding region and glycoproteins.

Authors:  D R Spotts; R M Reich; M A Kalkhan; R M Kinney; J T Roehrig
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

10.  Indirect mouse model for the evaluation of potential antiviral compounds: results with Venezuelan equine encephalomyelitis virus.

Authors:  R W Kuehne; W L Pannier; E L Stephen
Journal:  Antimicrob Agents Chemother       Date:  1977-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.